Patents Assigned to Athpharma Limited
  • Treatment and prevention of gastrointestinal disease using antagonists of partial agonists of 5HT1a receptors
    Patent number: 7098232
    Abstract: The present invention provides a method for preventing and treating gastrointestinal diseases such as dyspepsia, irritable bowel disease and chemotherapy-associated nausea by administering an antagonist or partial agonist of 5HT1a receptors.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: August 29, 2006
    Assignee: Athpharma Limited
    Inventors: Timothy G. Dinan, Patrick W. N. Keeling
  • Pharmaceutical formulations for preventing drug tolerance
    Publication number: 20040091534
    Abstract: Isosorbide mononitrate formulations and methods of treatment are disclosed. The formulations and treatments provide for subtherapeutic levels of the mononitrate in a washout period to prevent nitrate tolerance.
    Type: Application
    Filed: April 23, 2003
    Publication date: May 13, 2004
    Applicant: Athpharma Limited
    Inventors: Edward James Geoghegan, Seamus Mulligan, Mary Margaret Foynes
  • Pharmaceutical formulations for preventing drug tolerance
    Patent number: 6641839
    Abstract: Isosorbide mononitrate formulations and methods of treatment are disclosed. The formulations and treatments provide for subtherapeutic levels of the mononitrate in a washout period to prevent nitrate tolerance.
    Type: Grant
    Filed: February 7, 1997
    Date of Patent: November 4, 2003
    Assignee: Athpharma Limited
    Inventors: Edward James Geoghegan, Seamus Mulligan, Mary Margaret Foynes